Jobs, Steve
Pancreatic Cancer: A Neglected Disease Despite Recent Focus
As the world mourns Steve Jobs' passing, attention is drawn to the disease he publicly battled: neuroendocrine pancreatic cancer. Unlike the more common and aggressive adenocarcinoma, Jobs' tumor had a five-year survival rate of 50% to 80%. However, the lack of awareness and funding for pancreatic cancer research